JP Morgan Chase’s Propanc Biopharma PPCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3 Buy
+1
New +$12 ﹤0.01% 8183

Other funds holding PPCB

JP Morgan Chase's PPCB Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Propanc Biopharma (PPCB) in Q3 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #8183 among its holdings.

4 funds tracked by Wall St. Rank hold PPCB as of Q3 2026.

  • JP Morgan Chase held 1 share of Propanc Biopharma worth $3 as of Q3 2026.
  • Propanc Biopharma was a new JP Morgan Chase position in Q3 2026.
  • Propanc Biopharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #8183 holding.
  • 4 funds tracked by Wall St. Rank held Propanc Biopharma as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.